The commercial success of our marketed products provides us with the resources to generate new clinical data defining their profiles and supports our development of new therapeutic advancements. In 2006, we leveraged our strong financial position to broaden our product portfolio and better position the company for long-term growth. As we bring new products into clinical development, our goal remains the same - to improve the lives of patients worldwide suffering from life-threatening diseases.

Marketed Products

Product Pipeline